Jasmin Straube

🚨 Call for Abstracts Now Open #NDLR2026 🚨 Only 1 week left to submit your abstracts! 🗓 Abstract submission closes 23 September 2025 🩸 Submit now: ndlr.org.au

We are thrilled to introduce our new #NDLR2026 Meet-the-Editor session, with esteemed Editors-in-Chief, Prof. Andrew Roberts Roberts from Blood and Prof. Jan Cools, @Hemasphere_EHA who will share their invaluable insights on publishing in high-impact hematology journals.

We are honoured to welcome clinician-scientist Prof @StevenLane_QIMR from @QIMRB_Institute as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.

We are honoured to welcome Professor John D. Crispino, from @StJude as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.

We are happy to announce some key dates for NDLR 2026. Hope to see you there!

A huge thank you to @LeukaemiaAus for sponsoring NDLR 2026!

We are excited to announce that Dr Elliot Stieglitz will be joining us at NDLR 2026. Hope to see you there. #NDLR2026

We are happy to announce that Dr Jad Othman will be coming to Adelaide for NDLR 2026. #NDLR2026

We are pleased to announce that A/Prof Jessica Nordlund will be joining us in Adelaide at #NDLR2026.

We are please to announce that Dr Lindsey Montefiori will be joining us as an invited speaker for NDLR 2026. #NDLR2026

We are pleased to announce the first of our invited speakers for the NDLR 2026 program Prof Ari Melnick @LabMelnick. #NDLR2026

The Scientific and Organising Committees would like to invite you to be a part of the New Directions in Leukaemia Research (NDLR) Meeting 2026 being held in Adelaide, Australia Mon 2 March - Wed 4 March 2026.

#OnlineFirst: Jak2V617F Reversible Activation Shows Its Essential Requirement in #MyeloproliferativeNeoplasms, by @JAK2TheFuture, @bowman_rl, @rosslevinemd, @RossLevineLab et al. bit.ly/3S8gvdx @MSKCancerCenter #mpnsm

We are hiring! My laboratory at Hannover Medical School is searching for a motivated postdoc to join our team for the work on a highly competitive research project in the field of chromatin biology in pre-malignant hematopoiesis. Interested? Apply here: tinyurl.com/ysdxu7de

A superteam of @JswLab and @bloodgenes presents a technical tour de force in the mtDNA lineage tracing field. Congrats to authors!

Only at #EHA2023 you get to have a drink with a tea rex.

Super excited to head to @EHA_Hematology #EHA2023 with the fambam and present our new data on #Myc driven immune escape in #AML of our recently published paper rdcu.be/ddIxD. Hope to see many of you nice and early at the Molecular Hematopoiesis Workshop Friday 8am! 😀

Study unravelling imetelstat treatment mechanism in AML by our teams talented Dr Claudia Bruedigam @cbruedigam in preprint. Check it out!

Excited to share our new paper on "Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia" @CD_AACR. Amazing collaboration with @iannisaifantis1 lab ,@glytsou @xufeng_chen . Work from our lab spearheaded by Manos Zacharioudakis. Congrats to all authors!

Our latest work. We examine immune responses in Acute Myeloid Leukaemia (AML). The oncogene that drives the AML also specifies the intensity and type of immune response. #immunotherapy Work by @rebeccajaustin1 @JStraubeBioinfo @megan_bywater @NatureComms rdcu.be/c9VRQ